Administration of progesterone to individuals treated for Traumatic Brain Injury (TBI) shortly after the injury has the potential of reducing the chances of death and degree of disability to a considerable extent, according to Emory University researchers.
The researchers said progesterone treatment for TBI has been extensively studied in lab animals for over 15 years with efficacy.
The research was published in the Annals of Emergency Medicine.